Dupilumab reduced rates of severe exacerbations and improved pre-bronchodilator FEV1 in patients with moderate to severe asthma regardless of exacerbation history: LIBERTY ASTHMA TRAVERSE

J. Corren, C. H. Katelaris, M. Castro, J. F. Maspero, M. Humbert, D. M. Halpin, A. Altincatal,N. Pandit-Abid, X. Soler,A. Radwan, J. A. Jacob-Nara, Y. Deniz,P. J. Rowe

ALLERGOLOGIE（2023）

引用 0|浏览0